Kepuasan Pengguna dan Manfaat Coretax dalam Administrasi Perpajakan Digital
Jurnal Akuntansi, Perpajakan dan Auditing · 16.07.2026 · 7 (1) · 97-106
DOI: 10.21009/japa.0701.08 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Akuntansi, Perpajakan dan Auditing, online erschienen am 16.07.2026. Verfasst von Rezky Akbar Setyanto Putra und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The purpose of this study is to assess the Coretax Administration System's deployment success using the DeLone and McLean Information System Success Model. The study looks at how user happiness affects net benefits as well as how system, information, and service quality affect user satisfaction. Data gathered from surveys given to Coretax customers was used in a quantitative manner. The Partial Least Squares-Structural Equation Modeling (PLS-SEM) approach was used to examine the data. The findings show that user satisfaction is positively and significantly impacted by system, information, and service quality. Additionally, net benefits are positively and significantly impacted by customer happiness. These results imply that enhancing system, information, and service quality can increase user satisfaction and optimize the advantages of implementing a digital tax system.
Zitieren
APA
Putra, R. A. S., Jaya, T. E., & Sasmi, A. A. (2026). Kepuasan Pengguna dan Manfaat Coretax dalam Administrasi Perpajakan Digital. Jurnal Akuntansi, Perpajakan dan Auditing, 7(1), 97-106. https://doi.org/10.21009/japa.0701.08
Vancouver
Putra RAS, Jaya TE, Sasmi AA. Kepuasan Pengguna dan Manfaat Coretax dalam Administrasi Perpajakan Digital. Jurnal Akuntansi, Perpajakan dan Auditing. 2026;7(1):97-106. doi:10.21009/japa.0701.08
BibTeX
@article{Putra2026,
author = {Putra, Rezky Akbar Setyanto and Jaya, Tresno Eka and Sasmi, Aji Ahmadi},
title = {Kepuasan Pengguna dan Manfaat Coretax dalam Administrasi Perpajakan Digital},
journal = {Jurnal Akuntansi, Perpajakan dan Auditing},
year = {2026},
volume = {7},
number = {1},
pages = {97--106},
doi = {10.21009/japa.0701.08}
}
EUVIMED